LISATA THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LISATA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $29.00K, a 60.81% decline year-over-year.
- LISATA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $205.00K, a 469.44% increase year-over-year.
- LISATA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $353.00K.
- LISATA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $74.00K, a 131.25% increase year-over-year.
- LISATA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $844.00K, a 1141.18% increase from fiscal 2024.
- LISATA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $68.00K, a 78.82% decline from fiscal 2023.
- LISATA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $321.00K, a 646.51% increase from fiscal 2022.
- LISATA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $43.00K, a 99.95% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $29.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $844.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $353.00K 10-Q · filed 2025-11-06 | $675.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $74.00K 10-Q · filed 2026-08-06 | $322.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $212.00K 10-Q · filed 2026-05-11 | $280.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $68.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-06-30 | $32.00K 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $321.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2023-06-30 | $297.00K 10-Q · filed 2024-08-12 | |
| 2022-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $43.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | |
| 2022-06-30 | $29.00K 10-Q · filed 2022-08-04 | |
| 2021-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $85.50M 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $85.49M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $22.00K 10-Q · filed 2022-08-04 | $94.52M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $85.46M 10-Q · filed 2022-05-05 | $104.19M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $18.73M 10-K · filed 2022-03-22 |
| 2020-09-30 | $9.03M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $9.68M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.31M 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.00K 10-Q · filed 2020-11-05 | $1.07M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $37.00K 10-Q · filed 2020-08-13 | $1.78M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $1.00M 10-Q · filed 2020-05-07 | $2.03M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $1.03M 10-K · filed 2020-03-05 |
| 2018-09-30 | $710.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $288.00K 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $22.37K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $5.70M 10-K · filed 2019-03-14 |
| 2017-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $5.59M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $37.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $13.79M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $3.24M 10-Q · filed 2018-05-10 | $13.71M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | -$90.32K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $11.56M 10-K · filed 2018-03-22 |
| 2016-09-30 | $10.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $11.99M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | -$45.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $1.39M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | $1.10M 10-Q · filed 2017-05-15 | $30.16M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $334.43K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $36.47M 10-K · filed 2017-03-17 |
| 2015-09-30 | $425.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $41.57M derived: sum of 4 quarters · filed 2016-11-07 |
| 2015-06-30 | $28.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $42.70M derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | $7.41M 10-Q · filed 2016-05-05 | $18.49M derived: sum of 4 quarters · filed 2016-05-05 |
| 2014-12-31 | $5.44M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $16.71M 10-K · filed 2016-03-15 |
| 2014-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $48.49M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $4.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $54.64M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $5.63M 10-Q · filed 2015-05-06 | $61.64M derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $37.22M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $58.74M 10-K · filed 2016-03-15 |
| 2013-09-30 | $7.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $25.79M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $11.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $20.73M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $2.73M 10-Q · filed 2014-05-08 | $11.47M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $16.43M 10-K · filed 2015-03-02 |
| 2012-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | |
| 2012-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | |
| 2012-03-31 | $7.69M 10-Q · filed 2013-05-09 | |
| 2011-12-31 | $21.15M 10-K · filed 2013-03-11 | |
| 2010-12-31 | $21.43M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |